Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone taper after methylprednisolone pulse for acute multiple sclerosis relapse
IRCT20120314009297N6Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Methylprednisolone pulse + prednisolone taper with Methylprednisolone pulse + placebo (2 arms). Primary endpoints: Functional Systems Scores, Assessing Relapse in Multiple Sclerosis and 2 more. Started Jun 2019; status: completed.
02
Drugs
prednisolonemethylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20120314009297N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120314009297N6.